JF
JAZZ icon

Jump Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jump Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,427
Closed -$550K – 1959
2025
Q1 		$550K Buy
+4,427
New +$578K 0.01% 1036
2024
Q4 		– Sell
-6,599
Closed -$735K – 1826
2024
Q3 		$735K Buy
+6,599
New +$723K 0.02% 943
2024
Q1 		– Sell
-29,782
Closed -$3.66M – 2095
2023
Q4 		$3.66M Buy
+29,782
New +$3.72M 0.12% 185
2023
Q3 		– Sell
-2,482
Closed -$308K – 2051
2023
Q2 		$308K Buy
+2,482
New +$334K 0.01% 1284
2023
Q1 		– Sell
-1,945
Closed -$310K – 1808
2022
Q4 		$310K Buy
+1,945
New +$285K 0.02% 1025

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Jump Financial's JAZZ Position: Q2 2025 in Review

Jump Financial sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 4,427 shares — an estimated $550K sold.

Jump Financial first reported a position in JAZZ in Q4 2022 and held it in 5 quarters. The position peaked at $3.66M in Q4 2023. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Jump Financial reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Jump Financial sold 4,427 Jazz Pharmaceuticals shares in Q2 2025, an estimated $550K.
  • Jump Financial first reported a position in Jazz Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Jump Financial's Jazz Pharmaceuticals position peaked at $3.66M in Q4 2023.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.